Gofen & Glossberg’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $927K | Sell |
22,096
-5,060
| -19% | -$205K | 0.02% | 250 |
|
|
2022
Q3 | $987K | Buy |
27,156
+4,021
| +17% | +$164K | 0.03% | 233 |
|
|
2022
Q2 | $944K | Sell |
23,135
-24
| -0.1% | -$1.07K | 0.03% | 238 |
|
|
2022
Q1 | $1.11M | Buy |
23,159
+3
| +0% | +$146 | 0.03% | 238 |
|
|
2021
Q4 | $1.18M | Sell |
23,156
-327
| -1% | -$16.8K | 0.03% | 232 |
|
|
2021
Q3 | $1.19M | Buy |
23,483
+7,407
| +46% | +$385K | 0.03% | 231 |
|
|
2021
Q2 | $828K | Buy |
16,076
+1,070
| +7% | +$55.2K | 0.02% | 262 |
|
|
2021
Q1 | $737K | Buy |
15,006
+1,625
| +12% | +$79.4K | 0.02% | 272 |
|
|
2020
Q4 | $632K | Buy |
13,381
+210
| +2% | +$9.24K | 0.02% | 279 |
|
|
2020
Q3 | $539K | Sell |
13,171
-250
| -2% | -$10.3K | 0.02% | 285 |
|
|
2020
Q2 | $521K | Sell |
13,421
-3,265
| -20% | -$119K | 0.02% | 273 |
|
|
2020
Q1 | $556K | Sell |
16,686
-3,123
| -16% | -$125K | 0.02% | 250 |
|
|
2019
Q4 | $873K | Buy |
19,809
+4,828
| +32% | +$206K | 0.03% | 226 |
|
|
2019
Q3 | $615K | Buy |
14,981
+2
| +0% | +$82 | 0.02% | 258 |
|
|
2019
Q2 | $625K | Sell |
14,979
-800
| -5% | -$33K | 0.02% | 258 |
|
|
2019
Q1 | $645K | Sell |
15,779
-258
| -2% | -$10.3K | 0.02% | 239 |
|
|
2018
Q4 | $595K | Buy |
16,037
+3,485
| +28% | +$138K | 0.02% | 242 |
|
|
2018
Q3 | $543K | Hold |
12,552
| – | – | 0.02% | 279 |
|
|
2018
Q2 | $538K | Buy |
12,552
+250
| +2% | +$11.1K | 0.02% | 270 |
|
|
2018
Q1 | $544K | Buy |
12,302
+447
| +4% | +$20.3K | 0.02% | 266 |
|
|
2017
Q4 | $532K | Buy |
11,855
+5,000
| +73% | +$221K | 0.02% | 285 |
|
|
2017
Q3 | $298K | Sell |
6,855
-135
| -2% | -$5.73K | 0.01% | 382 |
|
|
2017
Q2 | $289K | Sell |
6,990
-496
| -7% | -$20.2K | 0.01% | 381 |
|
|
2017
Q1 | $294K | Sell |
7,486
-680
| -8% | -$26.1K | 0.01% | 374 |
|
|
2016
Q4 | $298K | Sell |
8,166
-410
| -5% | -$15K | 0.01% | 349 |
|
|
2016
Q3 | $321K | Hold |
8,576
| – | – | 0.01% | 342 |
|
|
2016
Q2 | $303K | Buy |
8,576
+262
| +3% | +$9.47K | 0.01% | 349 |
|
|
2016
Q1 | $298K | Buy |
8,314
+40
| +0.5% | +$1.38K | 0.01% | 348 |
|
|
2015
Q4 | $304K | Sell |
8,274
-8,530
| -51% | -$320K | 0.01% | 343 |
|
|
2015
Q3 | $599K | Buy |
16,804
+641
| +4% | +$24.6K | 0.03% | 258 |
|
|
2015
Q2 | $641K | Buy |
16,163
+513
| +3% | +$21.2K | 0.03% | 249 |
|
|
2015
Q1 | $623K | Hold |
15,650
| – | – | 0.03% | 252 |
|
|
2014
Q4 | $593K | Buy |
+15,650
| New | +$606K | 0.03% | 259 |
|
|
2014
Q2 | – | Sell |
-3,250
| Closed | -$136K | – | 506 |
|
|
2014
Q1 | $136K | Hold |
3,250
| – | – | 0.01% | 456 |
|
|
2013
Q4 | $135K | Buy |
3,250
+1,340
| +70% | +$54.3K | 0.01% | 453 |
|
|
2013
Q3 | $76K | Sell |
1,910
-2,420
| -56% | -$92.1K | ﹤0.01% | 461 |
|
|
2013
Q2 | $154K | Buy |
+4,330
| New | +$162K | 0.01% | 400 |
|
Other funds holding VEA
AWA
Gofen & Glossberg's VEA Position: Q4 2022 in Review
Gofen & Glossberg reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 19% in Q4 2022, selling an estimated $205K and leaving 22,096 shares worth $927K. The position accounts for 0.02% of the portfolio, ranked #250.
Gofen & Glossberg first reported a position in VEA in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.19M in Q3 2021. 1,854 funds tracked by Wall St. Rank hold VEA as of Q4 2022.
- Gofen & Glossberg held 22,096 shares of Vanguard FTSE Developed Markets ETF worth $927K as of Q4 2022.
- Gofen & Glossberg sold 5,060 Vanguard FTSE Developed Markets ETF shares in Q4 2022, an estimated $205K.
- Vanguard FTSE Developed Markets ETF made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #250 holding.
- Gofen & Glossberg first reported a position in Vanguard FTSE Developed Markets ETF in Q2 2013 and has held it in 37 quarters since.
- Gofen & Glossberg's Vanguard FTSE Developed Markets ETF position peaked at $1.19M in Q3 2021.
- 1,854 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.